Quantum BioPharma achieve 91% increase in Shareholder Equity and Liquidity in Q3 2026 as Lucid-MS Phase 2 Trial Advances into Study Start-Up

GlobeNewswire · 财报与经营业绩 · November 13, 2026 at 7:05 AM ET

Read the full report at the original publisher.